- Supply agreement supports Viridian’s development of potential first- and best-in-class subcutaneous therapies for treatment of thyroid eye disease (TED) - - Ypsomed brings strong track record of ...
Using biopolymers and taking a circular product design approach, Ypsomed has developed what it calls “the world’s first zero-carbon-emission prefilled autoinjector.” "We must take responsibility for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results